Cancer Family
Vascular Neoplasm
CI-CAN-00000385Explore in graph →
Non-malignant54 active trials4 approved drugs8 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000385Explore in graph →
Clinical trials
307 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02137564 | Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma | withdrawn | Phase 2 | 0 | AIDS Malignancy ConsortiumNETWORK | 0 | Jul 23, 2015 | clinicaltrials |
| NCT01290484 | A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations | completed | Phase 1 / Phase 2 | 7 | Stanford UniversityOTHER | 1 | Jun 19, 2015 | clinicaltrials |
| The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver |
| completed |
| N/A |
| 40 |
| Medical University of ViennaOTHER |
| 1 |
| Apr 7, 2015 |
| clinicaltrials |
| NCT00004436 | Randomized Study of Hormonal Regulation of Infantile Hemangioma | completed | N/A | 30 | FDA Office of Orphan Products DevelopmentFED | 0 | Mar 25, 2015 | clinicaltrials |
| NCT02351245 | Clinical Characteristics of Lip Hemangiomas | unknown | — | 39 | Zhujiang HospitalOTHER | 0 | Jan 30, 2015 | clinicaltrials |
| NCT01072045 | Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma | completed | Phase 2 | 50 | University of Sao PauloOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT01211080 | Off Label Use of Propranolol for Infancy Hemangiomas(PIHS) | completed | — | 72 | Hannover Medical SchoolOTHER | 1 | Nov 11, 2014 | clinicaltrials |
| NCT00834457 | A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe | completed | Phase 2 / Phase 3 | 49 | Parirenyatwa HospitalOTHER | 1 | Oct 30, 2014 | clinicaltrials |
| NCT01512173 | Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo | completed | Phase 2 | 82 | Pierre Fabre DermatologyINDUSTRY | 3 | Oct 30, 2014 | clinicaltrials |
| NCT00444379 | Anti-Retrovirals for Kaposi's Sarcoma(ARKS) | completed | Phase 4 | 224 | University of California, San FranciscoOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00974129 | A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas | withdrawn | — | 0 | Yale UniversityOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00245102 | Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma | completed | Phase 2 | 147 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00521092 | Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | May 5, 2014 | clinicaltrials |
| NCT00394888 | Hemangioma Associated With High Rates of Morbidity | completed | N/A | 433 | Medical College of WisconsinOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00555464 | Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas | terminated | Phase 2 | 8 | Medical College of WisconsinOTHER | 1 | Jun 11, 2013 | clinicaltrials |
| NCT00064142 | Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00433940 | Immune Suppression Of Infants Treated With Steroids | completed | — | 16 | Medical College of WisconsinOTHER | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00003350 | Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma | completed | Phase 3 | 240 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00577213 | Diagnosis of Hemangiomas and Vascular Malformations | completed | — | 56 | University of ArkansasOTHER | 0 | Oct 26, 2012 | clinicaltrials |
| NCT01015300 | Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease | terminated | Early Phase 1 | 1 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00001059 | Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS | completed | Phase 2 | 120 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Apr 17, 2012 | clinicaltrials |
| NCT00051597 | A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies | completed | Phase 1 / Phase 2 | 70 | Seagen Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00374335 | Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas | completed | N/A | 261 | Children's Mercy Hospital Kansas CityOTHER | 1 | Sep 16, 2011 | clinicaltrials |
| NCT00587912 | AIDS and Cancer Specimen Bank (ACSB) | completed | — | 65 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 21, 2011 | clinicaltrials |
| NCT01329458 | Contrast Enhanced Ultrasound For The Evaluation Of Focal Liver Lesions(HepFocUS) | unknown | — | 1,500 | Societatea Romana de Ultrasonografie in Medicina si BiologieOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00380770 | HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT(KAART) | completed | Phase 4 | 112 | University of KwaZuluOTHER | 1 | Jul 21, 2010 | clinicaltrials |
| NCT00002366 | The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma | completed | Phase 2 | — | AbbottINDUSTRY | 1 | Feb 20, 2009 | clinicaltrials |
| NCT00001120 | A Study of Patients With AIDS Syndrome | completed | — | 5,000 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Sep 12, 2008 | clinicaltrials |
| NCT00001294 | Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens | completed | — | 2,000 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001417 | Direct Injection of Alcohol for the Treatment of Spinal Tumors | completed | — | 30 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026728 | Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States | completed | — | 20,169 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001535 | Twins Study of Gene Therapy for HIV Infection | completed | Phase 1 | 48 | National Human Genome Research Institute (NHGRI)NIH | 1 | Feb 8, 2008 | clinicaltrials |
| NCT00601016 | A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy | completed | Phase 2 | 18 | St. Justine's HospitalOTHER | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00490607 | A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities | unknown | — | — | Rady Children's Hospital, San DiegoOTHER | 1 | Jun 25, 2007 | clinicaltrials |
| NCT00002093 | A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. | completed | Phase 3 | — | Nexstar PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002105 | Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma | completed | Phase 3 | 220 | Sequus PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002131 | A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 28 | Otsuka America PharmaceuticalINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002136 | A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days | completed | Phase 1 | — | Daiichi PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002137 | A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 | completed | Phase 1 | — | Daiichi PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002138 | A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. | completed | Phase 1 | — | Daiichi PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002147 | Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. | completed | Phase 3 | — | Sequus PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002153 | Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders | completed | Phase 1 | 25 | DEKK-TEC, Inc.INDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002167 | Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. | completed | Phase 2 | 78 | Clinical SolutionsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002185 | A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 | completed | Phase 2 | 20 | Agouron PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002188 | A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 27 | Anderson Clinical ResearchINDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
| NCT00002189 | Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals | completed | Phase 2 | — | Baker Norton PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002212 | A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 2 | 27 | Ligand PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002226 | Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma | completed | N/A | 30 | SUGENINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002259 | Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma | completed | Phase 2 | — | Lederle LaboratoriesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00002262 | A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma | completed | Phase 1 | — | University of California, San FranciscoOTHER | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jul 23, 2015source: clinicaltrials